Wide variability in the use of antimicrobial lock therapy and prophylaxis among infectious diseases consultants

Infection Control and Hospital Epidemiology

Volumn 31, Issue 5, 2010, Pages 554-557

  Polgreen, Philip M ^a,b   Beekmann, Susan E ^a   Diekema, Daniel J ^a   Sherertz, Robert J ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIMICROBIAL THERAPY; ARTICLE; BLOODSTREAM INFECTION; CLINICAL PRACTICE; HUMAN; INFECTION; INTRAVENOUS CATHETER; PHYSICIAN; PROPHYLAXIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; CONSULTANTS; DRUG UTILIZATION; HEALTH CARE SURVEYS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 77951031499     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/652153     Document Type: Article

References (8)

1. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49(1):1-45.
2. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 2006;43(4):474-484. (Pubitemid 44157156)
3. van de Wetering MD, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter gram positive infections in oncology patients. Cochrane Database Syst Rev 2007;(1):CD003295.
4. Sanders J, Pithie A, Ganly P, et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother 2008;62(4):809-815.
5. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47(1):83-93. (Pubitemid 351920592)
6. Infectious Diseases Society of America Emerging Infections Network's query: antimicrobial lock prophylaxis and treatment of catheter-related bloodstream infections. http://www.int-med.uiowa.edu/research/ein/Antibiotic- lock-survey.pdf. Accessed March 9, 2010.
7. Raad I, Hanna H, Jiang Y, et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007;51(5):1656-1660. (Pubitemid 46744141)
8. Fortun J, Grill F, Martin-Davila P, et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 2006;58:816-821. (Pubitemid 44390959)